Elixir Medical Corporation
Horia Grosu is an experienced professional in commercial operations and technology management, currently serving as the Senior Director of Commercial Operations at Elixir Medical Corporation since February 2025. Prior to this role, Horia held the position of Director of Commercial Operations at Aerin Medical, where collaboration with senior leadership and cross-functional teams facilitated the development of strategic commercial plans. Horia's career includes significant roles at Silk Road Medical, Inc. as Associate Director of Enterprise Architecture, focusing on strategic technology direction, and earlier positions at DFINE, Inc., Covidien, and BÂRRX Medical, where responsibilities spanned commercial operations and information technology. Horia holds an MBA from Santa Clara University's Leavey School of Business and dual degrees in Computer Science and Business Management Economics from the University of California, Santa Cruz.
This person is not in any teams
This person is not in any offices
Elixir Medical Corporation
Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Since 2005, the company has continually sought to improve the treatment of vascular disease with: - Drug-eluting coronary stent systems (DES) - Fully resorbable drug-eluting scaffold systems (BRS) - Drug-eluting coronary bioadaptor systems Its latest innovation — the DynamX™ Coronary Bioadaptor System — is designed to be a significant advancement beyond drug-eluting stents (DES). Elixir Medical’s innovations are designed to make a meaningful change in patients’ lives. The company does not simply want to engineer a better medical device. Saving lives and helping patients enjoy their daily life is what drives us every day.